Amide substituted xanthine derivatives with gluconeogenesis modulating activity

Details for Australian Patent Application No. 2003236702 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Huby, Nicholas John Silvester; Pietranico-Cole, Sherrie Lynn; Foley, Louise Helen; Dunten, Pete William; Yun, Weiya

Agent Spruson & Ferguson

Pub. Number AU-B-2003236702

PCT Number PCT/EP03/05922

PCT Pub. Number WO2003/106459

Priority 60/388,164 12.06.02 US

Filing date 5 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 8 March 2007

International Classifications

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/522 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 473/02 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/06 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/388,164 12.06.02 US

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003236702

8 March 2007 Application Accepted

  Published as AU-B-2003236702

5 July 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236703-MINIMIZATION FUNCTION FOR A COMPUTER USER INTERFACE

2003236701-GUANIDINO PHENYLALANIN COMPOUNDS USED AS UROKINASE INHIBITORS